Featured News

Our Partners

Latest News

D.C.-Based 60 Degrees Pharmaceuticals Sets January 2027 Readout for Babesiosis Study, Plans FDA Pre-sNDA Meeting

60 Degrees Pharmaceuticals, a Washington, D.C.-based company developing medicines for vector-borne disease, announced on October 6, 2026 that it will conclude enrollment in its randomized clinical study of tafenoquine in patients hospitalized with severe babesiosis at 30 patients. The company plans to unblind the study and report primary and secondary endpoint results in January 2027, […]

People on the Move: Dr. Joe Mitchell Succeeds Madeline Bell as President and CEO of Children’s Hospital of Philadelphia

CHOP marks a new chapter as Bell retires after nearly 40 years and Mitchell takes the helm. Children’s Hospital of Philadelphia (CHOP) has completed a planned leadership transition. On October 1, 2026, Madeline Bell retired as Chief Executive Officer after a career spanning nearly 40 years at CHOP, and Joseph (Joe) Mitchell, MD, the hospital’s […]

Greater Philadelphia’s Life Sciences and Healthcare Leaders Shine at the 2026 Philadelphia ORBIE Awards

The 2026 Philadelphia ORBIE Awards, presented by PhillyCIO and PhillyCISO, part of the Inspire Leadership Network, honored the region’s top technology and security executives on September 25, 2026, at the Philadelphia Marriott Downtown. The ORBIEs recognize chief information officers (CIOs) and chief information security officers (CISOs) for leadership, innovation, and impact, across categories ranging from […]

Buzzin’ Brood Student Spotlight: Susannah Kirby, George Mason University

BioBuzz’s Buzzin’ Brood Student Spotlight series celebrates the future of life sciences talent — and the programs, institutions, and organizations investing in them. Name: Susannah Kirby, B.S. Hometown: Loudoun County, Virginia Institution: George Mason University (Fairfax, Virginia) Role: MS Biostatistics Student, George Mason University (Class of 2027) Susannah Kirby, B.S. is a microbiologist turned data […]

Secretome Therapeutics Launches THRIVE-2 Phase 2 Study of STM-01 in Duchenne Muscular Dystrophy

Secretome Therapeutics, a clinical-stage biotechnology company developing therapies derived from neonatal cardiac progenitor cells (nCPCs), has announced the start of THRIVE-2, a Phase 2 clinical study evaluating its investigational therapy STM-01 in patients with Duchenne muscular dystrophy (DMD). The study is now open for enrollment, with the first patient expected to enroll imminently. “The initiation […]

Mooresville’s Chilipad Partners With National Breast Cancer Foundation to Bring Better Sleep to People Affected by Breast Cancer

Chilipad, the North Carolina sleep technology company behind the water-based Chilipad 2.0 cooling system, has launched a year-long partnership with the National Breast Cancer Foundation (NBCF). As part of the partnership, Chilipad is committing $50,000 worth of its sleep technology to men and women affected by breast cancer. The collaboration also includes a limited-edition pink […]

TregTherapeutics Taps Eva Garland Consulting to Power Non-Dilutive Funding Strategy

Treg Therapeutics, a biotech developing therapies designed to restore immune tolerance, has announced a partnership with Eva Garland Consulting (EGC) to strengthen its non-dilutive funding strategy. The company is advancing its autoimmune tolerance platform and development programs, aiming for therapies that can restore immune tolerance rather than simply suppress the immune system. “For an emerging […]

Baltimore’s SereNeuro Therapeutics Closes Oversubscribed Pre-Seed Financing to Advance Non-Opioid Pain Pipeline 

SereNeuro Therapeutics, a preclinical-stage biotechnology company developing non-opioid therapies for pain, has announced today, the close of its oversubscribed pre-seed financing. The round advances the company’s lead program, SN101, toward Investigational New Drug (IND)-enabling activities and supports its second program, SN102. Qualifying investors structured their investments through Maryland’s Biotechnology Investment Incentive Tax Credit at the […]